Received for publication September 28, 2005.
Revised January 19, 2006.
Accepted for publication January 31, 2006.

Effect of P-glycoprotein on intestinal absorption and brain penetration of anti-allergic agent bepotastine besilate

Abstract

The anti-allergic agent bepotastine besilate is a non- sedating, second-generation H1-antagonist with high oral absorption and negligible distribution into brain. To clarify the role of P-gp in the pharmacokinetics of bepotastine, the intestinal absorption and brain penetration studies were performed. [¹⁴C] Bepotastine transport in P-gp overexpressed LLC-PK1 cells indicated that bepotastine was a substrate of P- gp. The affinity of bepotastine to P-gp estimated by ATPase activity assay was low with Km value of 1.25 mM. Following intravenous administration, the brain-to- plasma free concentration ratio in mdr1-knockout mice was three times higher than that in wild-type mice. The in situ intestinal absorption studies of [¹⁴C] bepotastine in rats demonstrated a clear regional difference, showing highest permeability at upper part of small intestine with a decreasing permeability in descending part of small intestine. The apparent absorption rate constant (ka) of [¹⁴C] bepotastine in the small intestine was greatly increased by cyclosporin A and verapamil, especially in the distal portion, and the site-specific absorption of [¹⁴C]bepotastine disappeared. The concentration dependence of ka of [¹⁴C] bepotastine was observed with a higher ka at higher concentration (20 mM) compared with that at lower concentration (1 µM). In conclusion, bepotastine is a substrate for P-gp and P-gp clearly limited the brain distribution of bepotastine, while the effect of P-gp on intestinal absorption of bepotastine was minimal presumably due to high membrane permeability at the upper region of small intestine where P-gp is less expressed. Such intestinal absorption property of bepotastine is distinctly different from the low membrane permeable P-gp substrate fexofenadine.

Key words: ABC transporters, absorption, blood-CNS transport, intestinal transport, mass spectrometry, membrane transport, oral absorption, p-glycoprotein, pharmacokinetics

This article has been cited by other articles:

				H. Okumura, M. Katoh, T. Sawada, M. Nakajima, Y. Soeno, H. Yabuuchi, T. Ikeda, C. Tateno, K. Yoshizato, and T. Yokoi Humanization of Excretory Pathway in Chimeric Mice with Humanized Liver Toxicol. Sci., June 1, 2007; 97(2): 533 - 538. [Abstract] [Full Text] [PDF]

				J. Cao, X. Chen, J. Liang, X.-Q. Yu, A.-L. Xu, E. Chan, D. Wei, M. Huang, J.-Y. Wen, X.-Y. Yu, et al. Role of P-glycoprotein in the Intestinal Absorption of Glabridin, an Active Flavonoid from the Root of Glycyrrhiza glabra Drug Metab. Dispos., April 1, 2007; 35(4): 539 - 553. [Abstract] [Full Text] [PDF]